Bridgewater Associates’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,686
| Closed | -$335K | – | 676 |
|
|
2024
Q4 | $335K | Sell |
3,686
-9,138
| -71% | -$830K | ﹤0.01% | 618 |
|
|
2024
Q3 | $1.24M | Sell |
12,824
-14,189
| -53% | -$1.37M | 0.01% | 573 |
|
|
2024
Q2 | $2.48M | Sell |
27,013
-2,597
| -9% | -$238K | 0.01% | 494 |
|
|
2024
Q1 | $2.73M | Sell |
29,610
-5,036
| -15% | -$464K | 0.01% | 454 |
|
|
2023
Q4 | $3.29M | Sell |
34,646
-3,628
| -9% | -$345K | 0.02% | 434 |
|
|
2023
Q3 | $3.57M | Buy |
38,274
+3,179
| +9% | +$297K | 0.02% | 408 |
|
|
2023
Q2 | $3.21M | Sell |
35,095
-4,128
| -11% | -$377K | 0.02% | 387 |
|
|
2023
Q1 | $2.88M | Sell |
39,223
-980
| -2% | -$72.1K | 0.02% | 402 |
|
|
2022
Q4 | $3.36M | Sell |
40,203
-10,966
| -21% | -$916K | 0.02% | 440 |
|
|
2022
Q3 | $4.95M | Sell |
51,169
-184
| -0.4% | -$17.8K | 0.03% | 379 |
|
|
2022
Q2 | $5.4M | Buy |
51,353
+3,364
| +7% | +$354K | 0.02% | 461 |
|
|
2022
Q1 | $8.27M | Buy |
47,989
+12,438
| +35% | +$2.14M | 0.03% | 336 |
|
|
2021
Q4 | $5.76M | Buy |
35,551
+1,502
| +4% | +$243K | 0.03% | 265 |
|
|
2021
Q3 | $5.08M | Sell |
34,049
-1,225
| -3% | -$183K | 0.03% | 287 |
|
|
2021
Q2 | $8.64M | Buy |
35,274
+16,190
| +85% | +$3.97M | 0.06% | 237 |
|
|
2021
Q1 | $5.05M | Buy |
19,084
+246
| +1% | +$65.1K | 0.04% | 224 |
|
|
2020
Q4 | $5.53M | Buy |
18,838
+10,932
| +138% | +$3.21M | 0.05% | 186 |
|
|
2020
Q3 | $1.87M | Buy |
+7,906
| New | +$1.87M | 0.02% | 269 |
|